Hepatect Cp (Human Hepatitis B Immunoglobulin)

Hepatect Cp is indicated for use in individuals who have been exposed to hepatitis B virus and require immediate immune protection. It is commonly employed in the following clinical situations:

• Post‑exposure prophylaxis after needlestick injuries or other occupational exposures.
• Prevention of hepatitis B infection in newborns of hepatitis B‑positive mothers.
• Supplementation for patients with inadequate response to hepatitis B vaccination.
• Protection for individuals with chronic liver disease at risk of HBV infection.
• Use in emergency settings where rapid immunity is needed.

Side effects of Hepatect Cp are generally related to the injection and immune response. They are categorized as follows:

Common

• Mild fever or chills.
• Localized pain, redness, or swelling at the infusion site.
• Headache.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe allergic reactions (anaphylaxis, urticaria, bronchospasm).
• Acute hemolysis.
• Thrombocytopenia or other blood dyscrasias.
• Renal impairment or acute kidney injury.
• Persistent high fever or systemic inflammatory response.

Before administering Hepatect Cp, healthcare providers should consider several safety measures. Important precautions include:

• Assess patient history for prior hypersensitivity to blood products or immunoglobulins.
• Monitor vital signs during and after infusion for signs of an allergic reaction.
• Use caution in patients with renal insufficiency; adjust infusion rate as needed.
• Evaluate for hepatitis B surface antigen status to confirm need for prophylaxis.
• Pregnant or breastfeeding individuals should be assessed on a case‑by‑case basis due to limited safety data.
• Ensure proper storage and handling to maintain product integrity.

Hepatect Cp may interact with other medications or conditions. Interaction guidance is grouped as follows:

Avoid

• Concurrent administration of other immunoglobulin products without appropriate spacing.
• Live vaccines administered within 3 months of Hepatect Cp due to potential interference with vaccine efficacy.

Use with caution

• Anticoagulants or antiplatelet agents, as infusion may increase bleeding risk.
• Immunosuppressive therapies, which could alter the expected immune response.
• Renal‑clearing drugs, given the potential for renal stress during infusion.
• Medications known to cause hypersensitivity reactions, requiring close monitoring.